Kenneth Aldape

94.5k total citations · 9 hit papers
369 papers, 27.8k citations indexed

About

Kenneth Aldape is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Kenneth Aldape has authored 369 papers receiving a total of 27.8k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Genetics, 158 papers in Molecular Biology and 119 papers in Cancer Research. Recurrent topics in Kenneth Aldape's work include Glioma Diagnosis and Treatment (193 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (40 papers). Kenneth Aldape is often cited by papers focused on Glioma Diagnosis and Treatment (193 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (40 papers). Kenneth Aldape collaborates with scholars based in United States, Canada and Germany. Kenneth Aldape's co-authors include Mark R. Gilbert, Gelareh Zadeh, Raymond Sawaya, Amy B. Heimberger, Margaret Wrensch, Dima Suki, Weiwei Yang, Yan Xia, Howard Colman and Andreas von Deimling and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kenneth Aldape

353 papers receiving 27.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

2011 846 citations Kenneth Aldape et al. profile →
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

2013 742 citations Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology profile →
Epidemiology and molecular pathology of glioma

2006 703 citations Kenneth Aldape et al. profile →
PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis

2012 672 citations Kenneth Aldape, W. K. Alfred Yung et al. profile →
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

2010 613 citations John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology profile →
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

2018 553 citations Kenneth Aldape, Howard Colman et al. profile →
Glioblastoma: pathology, molecular mechanisms and markers

2015 506 citations Kenneth Aldape, Gelareh Zadeh et al. profile →
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

2011 498 citations Kenneth Aldape et al. profile →
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

2020 310 citations Kenneth Aldape, Howard Colman et al. profile →

Peers

Countries citing papers authored by Kenneth Aldape

Since Specialization

Citations

This map shows the geographic impact of Kenneth Aldape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Aldape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Aldape more than expected).

Fields of papers citing papers by Kenneth Aldape

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Aldape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Aldape. The network helps show where Kenneth Aldape may publish in the future.

Co-authorship network of co-authors of Kenneth Aldape

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Aldape. A scholar is included among the top collaborators of Kenneth Aldape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Aldape. Kenneth Aldape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? 2024 ·Journal of Neuropathology & Experimental Neurology ·(unknown), (unknown), Derek R. Johnson, (unknown), (unknown), Vera Paulson, (unknown), Zied Abdullaev, Martha Quezado, Patrick J. Cimino, Drew Pratt, (unknown), (unknown), Dirce Maria Carraro, Giovana Tardin Torrezan, (unknown), Leslie Domenici Kulikowski, Felipe D’Almeida Costa, Kenneth Aldape, Cristiane M. Ida	4
2	Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma 2024 ·Cancer Research ·Nishanth Ulhas Nair, Alejandro A. Schäffer, E. Michael Gertz, Kuoyuan Cheng, Johanna Zerbib, Avinash Sahu, (unknown), Eldad D. Shulman, Kenneth Aldape, Uri Ben‐David, Eytan Ruppin	8
3	c-Src Phosphorylates and Inhibits the Function of the CIC Tumor Suppressor Protein 2020 ·Molecular Cancer Research ·Severa Bunda, Pardeep Heir, (unknown), Yasin Mamatjan, Gelareh Zadeh, Kenneth Aldape	14
4	Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas 2019 ·Clinical Cancer Research ·Hao‐Wen Sim, Romina Nejad, Wenjiang Zhang, Farshad Nassiri, Warren Mason, Kenneth Aldape, Gelareh Zadeh, Eric X. Chen	21
5	Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice 2015 ·Clinical Cancer Research ·Sun-Jin Kim, Ho Jeong Lee, (unknown), Hyun Jin Choi, Junqin He, Qiuyu Wu, Kenneth Aldape, Jeffrey S. Weinberg, W. K. Alfred Yung, Charles A. Conrad, Robert R. Langley, François Lehembre, Urs Regenass, Isaiah J. Fidler	50
6	Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target 2014 ·Clinical Cancer Research ·Guo Chen, Nitin Chakravarti, Kimberly Aardalen, Alexander J. Lazar, Michael T. Tetzlaff, Bradley Wubbenhorst, Sang-Bae Kim, Scott Kopetz, Alicia A. Ledoux, Y.N. Vashisht Gopal, Cristiano Gonçalves Pereira, Wanleng Deng, Ju‐Seog Lee, Katherine L. Nathanson, Kenneth Aldape, Víctor G. Prieto, Darrin D. Stuart, Michael A. Davies	120
7	Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses 2014 ·Clinical Cancer Research ·Apostolia M. Tsimberidou, Sijin Wen, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina A. Piha‐Paul, Aung Naing, Filip Jankú, Kenneth Aldape, (unknown), Razelle Kurzrock, Donald A. Berry	140
8	Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial breakdown → 2013 ·Journal of Clinical Oncology ·Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, (unknown), Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta	742
9	A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas 2011 ·The Journal of Experimental Medicine ·Sameer Agnihotri, Amparo Wolf, Diana M. Muñoz, Chris Smith, Aaron S. Gajadhar, Andrés Ramírez, Ian D. Clarke, Gregory N. Fuller, Santosh Kesari, Peter B. Dirks, C. Jane McGlade, William L. Stanford, Kenneth Aldape, Paul S. Mischel, Cynthia Hawkins, Abhijit Guha	65
10	Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study 2011 ·Journal of Clinical Oncology ·John de Groot, Kathleen R. Lamborn, Susan M. Chang, Mark R. Gilbert, Timothy F. Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank S. Lieberman, H. Ian Robins, Minesh P. Mehta, Andrew B. Lassman, Lisa M. DeAngelis, W.K. Alfred Yung, Alice P. Chen, Michael D. Prados, Patrick Y. Wen	168
11	Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition 2011 ·Cancer Research ·Wen‐Tai Chiu, Hsueh‐Te Lee, (unknown), Kenneth Aldape, Jun Yao, Patricia S. Steeg, Cheng-Yang Chou, Zhimin Lu, Keping Xie, Suyun Huang	55
12	Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma 2010 ·Cancer Research ·Bruno M. Costa, Justin S. Smith, Ying Chen, Justin Chen, Heidi Phillips, Kenneth Aldape, Giuseppe Zardo, Janice Nigro, C. David James, Jane Fridlyand, Rui Manuel Reis, (unknown)	122
13	Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma breakdown → 2010 ·Journal of Clinical Oncology ·John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner	613
14	Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma 2009 ·Clinical Cancer Research ·Michael A. Davies, Katherine Stemke‐Hale, E. Lin, Carmen S. Tellez, Wanleng Deng, Y.N. Vashisht Gopal, Scott E. Woodman, Tiffany L. Calderone, Zhenlin Ju, Alexander J. Lazar, Víctor G. Prieto, Kenneth Aldape, Gordon B. Mills, Jeffrey E. Gershenwald	159
15	Identification of noninvasive imaging surrogates for brain tumor gene-expression modules 2008 ·Proceedings of the National Academy of Sciences ·Maximilian Diehn, Christine Nardini, David S. Wang, Susan L. McGovern, Mahesh Jayaraman, Yu Liang, Kenneth Aldape, Soonmee Cha, Michael Kuo	345
16	Transgenic E2F1 Expression in the Mouse Brain Induces a Human-Like Bimodal Pattern of Tumors 2007 ·Cancer Research ·(unknown), D. Gale Johnson, Hong Jiang, Jing Xu, Marta M. Alonso, Kenneth Aldape, Gregory N. Fuller, B. Nebiyou Bekele, W.K. Alfred Yung, Candelaria Gomez‐Manzano, Juàn Fueyo	19
17	Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma 2007 ·Journal of Clinical Oncology ·Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Li Zhang, E. Lin, Erik P. Sulman, Krishna Bhat, J. Matthew McDonald, W.K. Alfred Yung, Howard Colman, Shiao Y. Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, Fred G. Barker, Jan C. Buckner, C. David James, Kenneth Aldape	239
18	Distinct Genetic Signatures among Pilocytic Astrocytomas Relate to Their Brain Region Origin 2007 ·Cancer Research ·Mukesh Kumar Sharma, David B. Mansur, Guido Reifenberger, Arie Perry, Jeffrey R. Leonard, Kenneth Aldape, (unknown), Ryan J. Emnett, Simon Loeser, Mark A. Watson, Rakesh Nagarajan, David H. Gutmann	125
19	Activation of Stat3 in Human Melanoma Promotes Brain Metastasis 2006 ·Cancer Research ·Tongxin Xie, (unknown), Kenneth Aldape, Shin-Hyuk Kang, Mingguang Liu, Jeffrey E. Gershenwald, Keping Xie, Raymond Sawaya, Suyun Huang	312
20	Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma 2005 ·Cancer Research ·Janice Nigro, Anjan Misra, Li Zhang, Ivan Smirnov, Howard Colman, Chandi Griffin, Natalie Ozburn, Mingang Chen, Edward Pan, Dimpy Koul, W.K. Alfred Yung, Burt G. Feuerstein, Kenneth Aldape	261

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact